Ontology highlight
ABSTRACT:
SUBMITTER: Liu ZB
PROVIDER: S-EPMC7133118 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
OncoTargets and therapy 20200331
Checkpoint immunotherapy is emerging as a new therapeutic approach for metastatic breast cancer. Monotherapy of immunoagents against PD1/PD-L1 or CTLA-4 has shown little efficacy in these patients. Recently, to determine the optimal use of immunotherapy, there has been a rapid expansion in the number of clinical trials developing immunotherapy combinations. These combination therapeutic approaches can enhance various aspects of cancer immunity, such as tumor antigenicity or intratumor T cell inf ...[more]